Serum adiponectin concentrations were found to be significantly higher in patients with COPD particularly in the phase of exacerbation, hence the hormone might represent an indirect marker of low-grade systemic inflammatory response and a severity of COPD [159]. Here, ADIPOQ is linked to chronic obstructive pulmonary disease.